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dc37 is a molecular chaperone required for folding
of protein kinases. It functions in association with
Hsp90, although little is known of its mechanism of
action or where it ﬁts into a folding pathway involving
other Hsp90 cochaperones. Using a genetic approach with
 
Saccharomyces cerevisiae
 
, we show that 
 
CDC37
 
 over-
expression suppressed a defect in v-Src folding in yeast
deleted for 
 
STI1
 
, which recruits Hsp90 to misfolded clients.
Expression of 
 
CDC37
 
 truncation mutants that were deleted
for the Hsp90-binding site stabilized v-Src and led to
C
 
some folding in both 
 
sti1
 
 
 
 and 
 
hsc82
 
 
 
 strains. The protein
kinase–binding domain of Cdc37 was sufﬁcient for yeast
cell viability and permitted efﬁcient signaling through the
yeast MAP kinase–signaling pathway. We propose a model
in which Cdc37 can function independently of Hsp90,
although its ability to do so is restricted by its normally low
expression levels. This may be a form of regulation by
which cells restrict access to Cdc37 until it has passed
through a triage involving other chaperones such as Hsp70
and Hsp90.
 
Introduction
 
The role of Hsp90 in protein folding appears to be restricted
to signal-transducing proteins, represented largely by steroid
hormone receptors and protein kinases (Caplan, 1999).
Although protein kinases represent a large and abundant
protein family, much more is known about Hsp90 mecha-
nism of action in folding of steroid hormone receptors (Pratt
and Toft, 1997). The overall scheme involves sequential
action by Hsp70/Hsp40 chaperones followed by Hsp90 and
several of its cochaperones. It is thought that Hsp70 acts
first by interacting with nascent polypeptide chains in asso-
ciation with Hsp40s. Should a client polypeptide require
Hsp90, then it must be recruited. This function is likely to
be performed by Hop, a cochaperone that interacts with
Hsp90 and Hsp70 via distinct tetratricopeptide repeat se-
quences (Chen et al., 1996; Scheufler et al., 2000). Hop also
regulates Hsp90s’ ATPase by stabilizing the ADP-bound
form of yeast Hsp90 and by inhibiting client-stimulated
ATP hydrolysis by the human homologue (Prodromou et
al., 1999; McLaughlin et al., 2002). Recruitment of Hsp90
via Hop leads to the establishment of an “intermediate”
complex containing the client polypeptide in association
with Hsp70/Hop–Hsp90. Hsp70 and Hop subsequently
dissociate from Hsp90 and are replaced by p23 and TPR-
containing immunophilins (Smith, 1993). The change from
intermediate to “mature” complexes is associated with a
change in nucleotide bound to Hsp90, since p23 binds only
to Hsp90-ATP (Johnson and Toft, 1995; Fang et al., 1998;
Grenert et al., 1999). These interactions ultimately result in
establishment of a hormone-binding competent conformation
by steroid receptors. Investigators that reconstituted this
pathway with purified proteins have proposed that Hsp70
and Hsp90 are the only essential chaperone components for
folding of glucocorticoid receptor (GR)* and that other co-
chaperones such as Hsp40 or Hop play supporting roles that
stimulate the reaction (Morishima et al., 2000; Rajapandi et
al., 2000). Similar studies with the closely related progesterone
receptor, however, showed that Hsp40, Hop, and p23 are
also necessary for folding and hormone binding (Kosano et
al., 1998). Similarly, studies with a viral reverse transcriptase
indicated that Hop and Hsp40, in addition to Hsp90 and
Hsp70, are required for activity, whereas p23 is not essential
but stimulates the reaction (Hu et al., 2002). The require-
ment of cochaperones for folding has also been demonstrated
in yeast, since deletion of 
 
YDJ1
 
 (a yeast Hsp40) or 
 
STI1
 
(yeast Hop) strongly affects the activity of exogenous Hsp90
clients such as the androgen receptor and v-Src (Caplan et al.,
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1995; Dey et al., 1996; Chang et al., 1997; Johnson and
Craig, 2000). It is likely that individual clients will have their
own conformational needs that manifest in the requirement
for different cochaperones in a form of tailoring.
Folding of protein kinases is assumed to follow a similar
pathway as for steroid receptors, with the exception that
another chaperone called Cdc37 is also required. Cdc37
does not interact with most steroid hormone receptors,
with the exception of the androgen receptor and a viral re-
verse transcriptase (Fliss et al., 1997; Rao et al., 2001;
Wang et al., 2002b). Cdc37 is an Hsp90-binding protein
that can also interact with unfolded or misfolded proteins
(Kimura et al., 1997). It binds to Hsp90 at a site distinct
from Hop or other TPR-containing cochaperones and may
be present in mature complexes that contain p23 and
immunophilins (Silverstein et al., 1998; Hartson et al.,
2000). Overexpression of Cdc37 in transgenic mice results
in hyperplasia and cancer when it is specifically targeted to
breast and prostate tissues (Stepanova et al., 2000a,b), sug-
gesting that Cdc37 expression must be tightly controlled.
This is supported by the finding that it is normally ex-
pressed at very low levels (Kimura et al., 1997) and is not
inducible under conditions that up-regulate other chaper-
ones and heat shock proteins.
For the present study, we adopted a genetic strategy to
understand the relationship between different chaperones
and cochaperones in the folding of a protein kinase. We
used v-Src as a test case because it is dependent on Hsp90
and its cochaperones for folding and activity. Our strategy
was to block formation of the “intermediate” complex by
analyzing yeast deleted for 
 
STI1
 
, the gene that encodes
Hop, which results in the loss of v-Src activity (Chang et
al., 1997) and then search for suppressors. Our results
show that Cdc37 is an effective suppressor of the v-Src
folding defect in 
 
sti1
 
 
 
 cells.
 
Results
 
STI1
 
 encodes an 
 
S. cerevisiae
 
 homologue of Hop, the hsp-
organizing protein that coordinates the combined action of
Hsp70 and Hsp90 on unfolded or misfolded proteins (Fryd-
man and Hohfeld, 1997). Deletion of 
 
STI1
 
 has little effect
on cell growth under normal conditions, but results in de-
creased growth rate at high temperatures (Nicolet and Craig,
1989). Even under normal growth conditions, however,
 
STI1
 
 is important for folding of the oncogenic tyrosine ki-
nase, v-Src, when heterologously expressed in yeast (Chang
et al., 1997)
 
.
 
 To further investigate chaperone function, we
searched for suppressors of v-Src loss of activity in yeast cells
deleted for 
 
STI1
 
 (
 
sti1
 
 
 
) using a reverse genetic approach.
Three genes were chosen for initial studies: 
 
CDC37
 
, 
 
SBA1
 
,
and 
 
CNS1
 
. CDC37 was chosen since it is essential for v-Src
folding yet its action within the pathway of chaperone action
is unknown. 
 
CNS1
 
 was chosen since it has some similarity
with 
 
STI1
 
 (Dolinski et al., 1998; Marsh et al., 1998). 
 
SBA1
 
is the yeast homologue of mammalian p23, which is thought
to function downstsream of Hop in steroid receptor activa-
tion and displayed genetic interactions with 
 
STI1
 
 (Smith,
1993; Bohen, 1998; Fang et al., 1998). Each of these genes
was overexpressed in 
 
sti1
 
 
 
 cells and v-Src induced by growth
in galactose-containing medium for 6 h. The short induction
period was necessary since prolonged expression of v-Src is
lethal to wild-type cells (Florio et al., 1994). Since yeast has
very little endogenous tyrosine kinase activity, it is possible to
measure v-Src activity with a monoclonal antiphosphoty-
rosine on Western blots using whole cell extracts. Induction
of v-Src in wild-type cells led to the appearance of multiple
bands that reacted with antiphosphotyrosine, as shown in
Fig. 1. The intensity of these bands was reduced in 
 
sti1
 
 
 
 cells
at 25
 
 
 
C, and almost disappeared when the cells were grown
at 30
 
 
 
C. The difference in v-Src activity when cells were
grown at the two temperatures partly correlates with the lev-
Figure 1. Cdc37 overexpression suppresses v-Src activity defect in sti1  yeast. (A) Western blot analysis using antiphosphotyrosine (top), 
anti–v-Src (middle), and antiphosphoglycerate kinase (bottom, Pak). Extracts were prepared after induction of v-Src for 6 h from wild type 
(lane 1) and sti1  strains minus and plus Cdc37 overexpression (lanes 2 and 3). Cells were grown at 25 C. (B) Extracts were prepared as 
describd for A, except that cells were grown at 30 C. (C) Pull-down assay with GST-Hsp90. V-Src was induced by growth of wild-type (WT) 
and sti1  cells in galactose-containing media. Lane 1, wild-type cells not expressing GST-hsp90; lane 2, wild-type cells expressing GST-Hsp90; 
lane 3, wild-type cells expressing GST-Hsp90 plus overexpressed Cdc37; lane 4, sti1  cells expressing GST-Hsp90; lane 5, sti1  cells 
expressing GST-Hsp90 plus overexpressed Cdc37. The bottom two panels show Western blots of proteins isolated on GST-agarose resin. The 
top two panels show Western blots of proteins in cell extracts. 
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els of v-Src, which were markedly lower at 30
 
 
 
C. The de-
creased levels of v-Src in the 
 
sti1
 
 
 
 strain did not reflect the
levels of all protein kinases in yeast, since we observed no de-
crease in the levels of phosphoglycerate kinase (Fig. 1, A and
B). Overexpression of 
 
SBA1
 
 or 
 
CNS1
 
 had no effect on v-Src
levels or activity in 
 
sti1
 
 
 
 cells (not shown). However,
 
CDC37
 
 overexpression resulted in increased v-Src activity at
close to wild-type levels. The suppression phenotype was
more pronounced when the cells were grown at 30
 
 
 
C com-
pared with those grown at 25
 
 
 
C (Fig. 1)
 
.
 
 
 
CDC37
 
 overexpres-
sion also lead to increased levels of v-Src, especially at 30
 
 
 
C,
perhaps by stabilizing the protein.
Our hypothesis regarding Cdc37 action in suppressing
v-Src loss of function in 
 
sti1
 
 
 
 yeast was based on the known or
proposed functions of both Hop and Cdc37 as recruitment
factors for Hsp90 (Stepanova et al., 1996; Frydman and Hoh-
feld, 1997). Both proteins bind to Hsp90 (at distinct sites;
Silverstein et al., 1998), although only Cdc37 has been char-
acterized to have chaperone activity. Thus, 
 
sti1
 
 
 
 deletion
may affect Hsp90 recruitment to v-Src, and 
 
CDC37
 
 overex-
pression may compensate for this loss by acting to bypass the
Hop requirement for Hsp90 recruitment. We therefore ana-
lyzed whether increasing Cdc37 dosage in 
 
sti1
 
 
 
 cells stimu-
lated v-Src binding to Hsp90 as a method of testing this hy-
pothesis. The experiment was performed by inducing v-Src
expression in yeast cells expressing GST-Hsp90 in the ab-
sence or presence of overexpressed Cdc37. Extracts from
these cells were used for pull-down assays to determine
whether or not v-Src was binding to Hsp90 (Fig. 1 C). In
wild-type cells, v-Src binding to Hsp90 was observed using
the pull-down assay and GST-tagged Hsp90 with or with-
out Cdc37 overexpression. By contrast, there was no observ-
able binding of v-Src to GST-Hsp90 in extracts from 
 
sti1
 
 
 
cells (Fig. 1 C), and Cdc37 overexpression failed to stimu-
late this association. These data support the hypothesis that
Sti1 functions to recruit Hsp90 to client proteins, since this
interaction was lost in the 
 
sti1
 
 
 
 strain. On the other hand, it
seems clear that Cdc37 does not substitute for Sti1 by pro-
moting stable recruitment of Hsp90 to v-Src in the 
 
sti1
 
 
 
strain.
The data shown in Fig. 1 C may be explained by one of
two possibilities; either Cdc37 functions in association with
Hsp90 but fails to promote stable association of Hsp90–
v-Src complexes, or it functions independently of Hsp90. To
differentiate between these two possibilities, we devised an
experimental strategy that uncoupled the ability of Cdc37 to
interact with v-Src from its ability to interact with Hsp90.
This strategy was based on prior studies showing that the
NH
 
2
 
-terminal region of human Cdc37 interacts with pro-
tein kinases, whereas the Hsp90-binding site resides toward
the middle portion of the protein (Grammatikakis et al.,
1999; Scholz et al., 2001). We confirmed this for interaction
between human Cdc37 and v-Src. In the experiment shown
in Fig. 2 B, we used purified full-length human Cdc37, or a
COOH-terminal truncation (Cdc37
 
1–173
 
) that was deleted
for the putative Hsp90-binding site. Incubation of these re-
combinant proteins in rabbit reticulocyte lysates resulted in
binding of Hsp90 to the full-length Cdc37 only, whereas in
vitro synthesized 
 
35
 
S-labeled v-Src bound to both proteins.
Based on these results, we generated a series of truncation
mutants of yeast Cdc37 that spanned the Hsp90-binding
site. Each contained an NH
 
2
 
-terminal His
 
6
 
 tag for subse-
quent detection by Western blot analysis. Of the eight mu-
tants that were generated, three failed to express in yeast,
whereas the rest were soluble (Fig. 2 D). We performed sev-
eral experiments to assay for interaction between His-tagged
Cdc3
 
7
 
 or the truncation mutants with Hsp90 in cell ex-
tracts, although we failed to detect any physical interactions.
Figure 2. Binding of v-Src to the NH2-terminal 
half of Cdc37 and construction of yeast Cdc37 
truncation mutants. (A) Schematic of human 
Cdc37 and the Cdc37
1–173 truncation mutant. The 
Hsp90-binding site is shown as a white box. (B) 
Binding of v-Src and Hsp90 to human His6Cdc37 
and His6Cdc37
1–173. V-Src protein was translated 
in rabbit reticulocyte lysates in the presence of 
[
35S]methionine and incubated with exogenous 
recombinant His6Cdc37 and His6Cdc37
1–173. 
Complexes were isolated on Ni-NTA resin and 
eluted with imidazole. Presence of Hsp90 in the 
eluates was determined by Western blot analysis 
(top). Presence of v-Src was determined by fluoro-
graphy (bottom). Lane 1, input (1% of the binding 
reaction); lane 2, binding reaction with resin only; 
lane 3, binding reaction with exogenous full-length 
Cdc37; lane 4, binding reaction with His6Cdc37
1–173. 
(C) Schematic of yeast Cdc37 and truncation 
mutants used in this study. The putative Hsp90-
binding site is shown as a white box (between 
amino acids 243 and 343) and is based on 
sequence similarity with human Cdc37. The limits 
for the Hsp90-binding site were deduced from 
previous studies (Grammatikakis et al., 1999; Scholz et al., 2001). All truncations were synthesized with an NH2-terminal 6-histidine tag. The 
ability of each truncation to be expressed in yeast (as determined by Western blot) is noted. (D) Western blot analysis of His6yCdc37 and the 
truncation mutants with anti-His6 after affinity chromatography with Ni-NTA resin. The bands labeled with an asterisk at 86 kD, and  50 kD 
are nonspecific. Molecular size standards are shown at left. 
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This is consistent with studies showing that interaction be-
tween yeast Cdc37 and Hsp90 is very weak (Kimura et al.,
1997; Siligardi et al., 2002).
We expressed each of the 
 
cdc37
 
 truncation mutants in
 
sti1
 
 
 
 yeast and tested whether any of them could suppress
the v-Src activity defect. These studies were performed at
both 25
 
 
 
C and 30
 
 
 
C. Remarkably, the Cdc37
 
1–388
 
 mutant
was as proficient as full-length Cdc37 for suppressing the
 
sti1
 
 
 
 phenotype, and its expression restored v-Src activity at
both temperatures. None of the other truncations was as ef-
fective in this regard, although even the Cdc37
 
1–148
 
 mutant
was capable of stabilizing v-Src protein when induced at
30
 
 
 
C in the 
 
sti1
 
 
 
 background and restoring a small amount
of v-Src activity (Fig. 3 B). None of the truncation mutants
smaller than Cdc37
 
1–388
 
 was very effective at suppressing the
v-Src activity defect in 
 
sti1
 
 
 
 at 25
 
 
 
C. This may reflect the
relative stability of v-Src at this lower temperature even in
the absence of Sti1 (Fig. 3, compare lane 2 of A with that of
B). The modest suppression phenotype observed at 30
 
 
 
C by
the two smaller truncations (Cdc37
 
1–235
 
 and Cdc37
 
1–148
 
)
may therefore relate to their ability to stabilize v-Src levels.
Since these smaller truncations were deleted for the putative
Hsp90-binding site, their function in activating v-Src may
be Hsp90 independent. However, there is a sharp drop in
v-Src activity in cells expressing truncated forms of Cdc37
smaller than Cdc37
 
1–388
 
, which correlates with loss of the
Hsp90-binding site (Fig. 3 B, compare lanes 3–7). These
combined data therefore suggest that Cdc37 cooperates with
Hsp90 when it is able to do so, although it can function in-
dependently in a less efficient manner when it has to.
We performed further studies to address the relationship
between Cdc37 and Hsp90 in v-Src activity. Our approach
was to test whether full-length or truncated versions of
Cdc37 could suppress v-Src activity defects arising from de-
creased levels of Hsp90. The rationale was to differentiate
between suppression due to Hsp90 interaction with Cdc37
versus Cdc37 being able to function by itself. Previous stud-
ies showed that deletion of the yeast 
 
HSC82
 
 gene caused a
substantial reduction in the cellular concentration of Hsp90
(by   90%) (Borkovich et al., 1989; Xu and Lindquist,
1993), with just enough expression from a second gene
(HSP82) to maintain cell viability. Previous studies also
demonstrated that v-Src was inactive in an hsc82  strain (Xu
and Lindquist, 1993), and that Cdc37 overexpression par-
tially suppressed v-Src loss of activity in a conditional hsp82
mutant (Kimura et al., 1997). We first confirmed that v-Src
activity was decreased in the hsc82 mutant (Fig. 4), and then
assayed for the ability of each Cdc37 truncation mutant to
suppress the v-Src activity defect. As shown in Fig. 4 A, the
results of this experiment were very similar to those observed
for the sti1  mutant, although overall levels of suppression
by full-length Cdc37 were reduced compared with the sti1 
strain (Fig. 3). The similarity between the results using
the  hsc82  and sti1  strains extended the findings that
Cdc37
1–388 was as effective as full-length Cdc37, whereas the
smaller Cdc37
1–335, Cdc37
1–239, and Cdc37
1–148 proteins were
effective, but to a lesser degree. Also, each truncation mutant
stabilized v-Src to a similar extent independently of its size.
Since the hsc82  strain was limiting for Hsp90 to begin
with, and the smaller truncations were deleted for the puta-
tive Hsp90-binding site, we conclude that Hsp90 is not es-
sential for Cdc37 function in protein kinase folding, but
that both chaperones cooperate to optimize the reaction.
One further possibility that was addressed is whether Cdc37
stimulated intrinsic Hsp90 activity. This was tested by ana-
lyzing the effect of Cdc37 on the activity of a protein that
depends on Hsp90 but is not a client of Cdc37. The GR
represents such a client, and its activity was analyzed in wild-
type and sti1  cells in which its activity was known to be re-
duced (Chang et al., 1997). GR activity was measured as
deoxycorticosterone induced  -galactosidase activity (from a
reporter plasmid under control of hormone responsive ele-
ments). In sti1  cells, the basal levels of  -galactosidase was
increased relative to that found in wild-type cells, but the in-
ducible levels were reduced (Fig. 4 B). The hormone-depen-
dent induction of  -galactosidase was therefore greatly re-
duced in sti1  cells compared with the wild-type from
30-fold induction to approximately sixfold induction. Im-
Figure 3. Effect of different Cdc37 
truncation mutants on v-Src activity in 
a sti1  strain. (A) Western blot analysis 
of tyrosine kinase activity (P-Tyr) by
v-Src in sti1  yeast overexpressing 
wild-type (lane 3) or truncated forms 
of CDC37 (lanes 4–7) as indicated. 
V-Src–dependent tyrosine kinase activity 
in wild-type cells and sti1  cells with 
empty vector is shown in lanes 1 and 2. 
Middle and bottom panels show levels 
of v-Src and phosphoglycerate kinase 
(PGK) proteins in the same extracts. 
Cells were grown at 25 C. (B) Extracts 
were prepared as described for A, 
except that the cells were grown at 30 C.Role of Cdc37 in protein kinase activity | Lee et al. 1055
portantly, Cdc37 overexpression had very little effect on GR
activity in either strain, suggesting that Cdc37 overexpres-
sion does not affect intrinsic Hsp90 activity.
These findings led us to test whether the protein kinase–
binding domain of Cdc37 was sufficient for yeast cell viabil-
ity. Yeast strains expressing truncated forms of Cdc37 con-
structed in a cdc37  deletion background isolated from
sporulated diploids. The growth phenotype of each haploid
was scored after tetrad dissection. The results from this study
demonstrated that all the truncated forms of Cdc37 could
support yeast cell growth with the exception of Cdc37
1–335.
Cells expressing the two smallest truncations, Cdc37
1–239
and Cdc37
1–148, were slow growing and displayed a tempera-
ture sensitive lethal phenotype at 37 C (Fig. 5 A). Further
studies addressed whether the viability of cells expressing the
truncations was dose dependent. We prepared plasmid con-
structs that expressed full length, Cdc37
1–388, Cdc37
1–335,
Cdc37
1–239, and Cdc37
1–148 from the same ADH promoter
on low copy number plasmids. This led to a significant de-
crease in the amount of expressed protein (Fig. 5 B). How-
ever, the amount of full-length Cdc37 expressed from the
ADH promoter from a low copy number plasmid was still
higher than wild-type chromosomal Cdc37 expressed from
its own promoter (not shown). Using a plasmid swap proce-
dure with 5-fluoroorortic acid, we then determined whether
these truncations in low copy number could support growth
of cdc37  yeast cells. In low copy, only full-length Cdc37
and Cdc37
1–388 suppressed the lethality of cdc37 . In high
copy, further suppression was observed by plasmids express-
ing Cdc37
1–239 and Cdc37
1–148, as expected based on the tet-
rad dissection analysis. The only truncation that failed to
support growth in either high or low copy was Cdc37
1–335
(not shown). These data demonstrate that the protein ki-
nase–binding domain of Cdc37 is sufficient for cell viability
if present in a high enough concentration. We also tested
whether these mutants could suppress the temperature-sen-
sitive lethal phenotype of cdc37–34, which has a point mu-
tation (serine 14 to leucine; Fliss et al., 1997). As expected,
the small truncations failed to do so since they failed to
promote growth of cdc37  at 37 C, although expression
of Cdc37
1–388 led to viable cells (Fig. 5 D). Interestingly,
Cdc37
1–335 expression had a negative effect on cdc37–34
growth at 25 C. These combined data indicate that the
COOH-terminal 118 amino acids of Cdc37 are dispensable
for normal function and that Cdc37
1–335 has abnormal func-
tion that is partially dominant–negative in cdc37–34.
The ability of Cdc37
1–148 to promote v-Src folding in sti1 
and hsc82  strains supports the hypothesis that Cdc37 is suf-
ficient for v-Src folding when Hsp90 is limiting or cannot be
recruited to the client. We further tested how well Cdc37
1–148
could substitute for full-length Cdc37 in cells that were wild
type for Hsp90 and Sti1. To this end, we induced v-Src in
cdc37  yeast cells that expressed Cdc37
1–148 from a multi-
copy plasmid. As shown in Fig. 6 A, the activity of v-Src was
much lower in the presence of Cdc37
1–148 compared with full
length Cdc37, similar to the results observed in hsp82  and
sti1  strains. However, a major difference was that the levels
of v-Src protein were also markedly lower in the cdc37 
background than in hsp82  and sti1  cells. We extended this
analysis to an endogenous protein kinase pathway. The sys-
tem used was signaling from the  -factor mating pheromone
via a G-protein–coupled receptor and the MAP kinase path-
way. Previous studies showed that one of the kinases in this
pathway, Ste11, interacts with Cdc37 and Hsp90, and that
signaling was impaired in cdc37 and hsp82 mutant strains
(Abbas-Terki et al., 2000). Using  -galactosidase as a re-
porter for this pathway, we tested how well Cdc37
1–148 could
substitute for full-length Cdc37. As shown in Fig. 6 B, there
was very little signaling in the cdc37–34 mutant, consistent
with a previous report (Abbas-Terki et al., 2000). However,
the Cdc37
1–148 truncation facilitated signal transmission at a
level that was  70% of the wild-type value. These data sug-
gest that folding is optimal when Cdc37 and Hsp90 interact
with each other, but is also quite strong in the presence of the
isolated protein kinase–binding domain of Cdc37.
Discussion
The role of Cdc37 in protein kinase folding has become
firmly established over the past few years. Cdc37 interacts
Figure 4. Effect of Cdc37 overexpression 
on v-Src activity in an hsc82  strain and 
GR in the sti1  strain. (A) Western blot 
analysis of tyrosine kinase activity (P-Tyr) 
by v-Src in hsc82  yeast overexpressing 
wild-type (lane 3) or truncated forms of 
CDC37 (lanes 4–7) as indicated. V-Src–
dependent tyrosine kinase activity in 
wild-type cells and hsc82  cells with 
empty vector is shown in lanes 1 and 2. 
Middle and bottom panels show levels 
of v-Src and phosphoglycerate kinase 
(PGK) proteins in the same extracts. 
Cells were grown at 30 C. (B) CDC37 
overexpression does not suppress loss 
of GR activity in sti1  cells. Wild-type 
(WT) and sti1  cells expressing GR were 
grown to mid-log phase and GR-dependent  -galactosidase activity was induced by addition of 1 M deoxycorticosterone. Gray bars represent 
basal  -galactosidase activity in wild-type or sti1  cells; black bars represent GR-dependent  -galactosidase activity in WT cells; hatched 
bars represent  -galactosidase activity in sti1  cells. The absence ( ) or presence ( ) of overexpressed CDC37 is noted. Fold induction
(ratio of induced  -galactosidase levels divided by basal levels) is shown above bars. Data shown are the mean of three independent
experiments   standard error.1056 The Journal of Cell Biology | Volume 159, Number 6, 2002
with many different protein kinases and facilitates their fold-
ing in association with Hsp90. Although the exact relation-
ship between these two chaperones is unknown, it has been
suggested that Cdc37 targets Hsp90 to misfolded protein ki-
nases (Stepanova et al., 1996). In this capacity, Cdc37
would bear some homology with Hop, which also recruits
Hsp90 to misfolded polypeptides bound to Hsp70 (Fryd-
man, 2001). In this report we show that CDC37 overexpres-
sion suppressed the defect in v-Src activity resulting from
deletion of STI1, the yeast Hop homologue.
The defect in v-Src activity in sti1  was temperature de-
pendent, with the defect being greater when the cells were
Figure 5. The protein kinase–binding domain of Cdc37 is sufficient for viability. (A) Spot test analysis of cdc37  cells expressing wild-type 
(Cdc37) or truncated versions of Cdc37 as indicated in the figure. 10-fold dilutions of saturated cultures were plated (3  l each) and incubated at 
30 C and 37 C. (B) Western blot analysis of proteins eluted from Ni-NTA resin after incubation with extracts expressing vector alone (lane 1 
or full-length histidine-tagged Cdc37 on a multicopy plasmid (lanes 2–5). Cdc37
1–239 was coexpressed with full-length Cdc37 on low copy 
number (lane 2) or high copy number plasmids (lane 4). Cdc37
1–148 was similarly expressed from low copy number or high copy number 
plasmids (lanes 3 and 5, respectively). Proteins that reacted with anti-His6 that bound nonspecifically to the resin are labeled with an asterisk. 
(C) Growth of cells expressing different forms of CDC37 from low copy or high copy number plasmids as indicated. Cells are shown spotted 
onto plates the absence or presence of 5-fluoroorotic acid (5-FOA) to counterselect for full-length Cdc37. (D) Spot test analysis of growth of 
cdc37–34 mutant yeast expressing truncated versions of Cdc37 as indicated. The cells were grown at 25 C or 37 C.
Figure 6. Protein kinase activity in 
cdc37  cells expressing Cdc37
1–148 
protein. (A) Phosphotyrosine activity in 
cells expressing v-Src. Lane 1, wild-type 
cells; lane 2, cdc37  cells expressing 
full-length Cdc37; lane 3, cdc37  cells 
expressing Cdc37
1–148. Western blot with 
anti-phosphotyrosine (top), Western blot 
with anti–v-Src (middle), and Western 
blot with anti-phosphoglycerate kinase 
(PGK) (bottom). (B)  -galactosidase 
activity as a measure of MAP kinase 
signaling. Cells treated with or without 
 -factor were assayed for Ste12-dependent 
lacZ gene expression. All strains were 
cdc37  expressing either cdc37–34, 
full-length Cdc37, or Cdc37
1–148 proteins 
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grown at 30 C compared with 25 C. This is correlated with
decreased levels of v-Src when the cells were grown at 30 C.
We interpret these findings in terms of v-Src being less sta-
ble at the higher temperature combined with its inability to
undergo refolding in the sti1  mutant. This defect probably
arises due to lack of Hsp90 recruitment to v-Src (Fig. 1 C).
Although overexpression of CDC37 suppressed the loss of
v-Src activity, it does so in a manner that is independent of
any stable recruitment of v-Src to Hsp90; although this
finding alone does not rule out the possibility that full-
length Cdc37 acts via Hsp90 in the suppression process.
Since Cdc37 and Hsp90 are only weakly interacting in
yeast, it is possible that Cdc37 interacts with both v-Src and
Hsp90 in sti1 , but in a complex that rapidly dissociates or
is sensitive to our extraction procedure. Our model is that
Cdc37 acts downstream of Sti1 in the folding pathway, and
that Sti1 normally functions to recruit Hsp90 (and perhaps
Cdc37) (Abbas-Terki et al., 2002) to misfolded clients al-
ready bound to Hsp70 (Fig. 7). The bypass function of
overexpressed CDC37 probably reflects the ability of Cdc37
protein to interact with both Hsp90 and v-Src. Since it is
normally expressed at low levels, Cdc37 probably represents
a limiting factor for protein kinase folding that must be re-
cruited to the client via interaction with Hsp90 and Sti1.
However, our results are also consistent with Cdc37 being
able to function in an Hsp90-independent manner. This is
because Cdc37 truncations lacking the Hsp90-binding site
were still functional for v-Src folding in sti1  and hsc82 
cells, albeit at reduced efficiency. The isolated protein ki-
nase–binding domain of Cdc37 was also sufficient for cell
viability and signaling via the MAP kinase–signaling path-
way (Figs. 5 and 6). However, whether Cdc37 can function
in a completely Hsp90-independent manner remains un-
clear, since is still possible that both chaperones could func-
tion together even though they fail to interact with each
other. Supporting this notion is the intriguing finding that a
truncated version of Cdc37 that failed to interact directly
with Hsp90 could still stimulate Hsp90 recruitment to a
protein kinase in animal cells, although this was far less than
the effect of full-length Cdc37 (Scholz et al., 2000). Thus, it
is still possible that truncated versions of Cdc37 could per-
mit association of a protein kinase with Hsp90, perhaps via
allosteric effects on the client itself. However, since Cdc37
1–148
facilitated some v-Src activity under conditions where Hsp90
could not be recruited to the client (Fig. 3), or was already
present in reduced amounts (Fig. 4), we propose that the
protein kinase–binding domain of Cdc37 is sufficient for a
limited amount of v-Src folding independently of Hsp90
function. We also conclude that the COOH-terminal 118
amino acids of Cdc37 are dispensable for function since
Cdc37
1–388 behaved just like full-length Cdc37 for v-Src
folding and cell viability (Figs. 3, 4, and 5). This is consis-
tent with a previous finding showing that cells expressing
Cdc37 truncated to amino acid 360 were viable but temper-
ature-sensitive for growth (Gerber et al., 1995).
Although Cdc37 overexpression suppressed loss of func-
tion by Hop and Hsp90, we have thus far been unable to
suppress defects in v-Src folding in YDJ1 mutant strains (Dey
et al., 1996) in the same manner. YDJ1 encodes an Hsp40
protein that functions in association with Hsp70 probably at
the earliest stages of protein folding (Cheetham and Caplan,
1998; Frydman, 2001). We have recently shown, however,
that SSE1 overexpression suppressed loss of v-Src activity in a
ydj1 mutant strain (Goeckeler et al., 2002). SSE1, a member
of the Hsp110 family, is similar in structure to Hsp70 and
also interacts with Hsp90 (Liu et al., 1999). It is therefore
possible that SSE1 suppressed defects in the ydj1 mutant be-
cause it has homologous action to Hsp70. This suggests that
Hsp70 function is an essential step in v-Src folding that can-
not be bypassed by Cdc37, unlike the actions of Sti1 or
Hsp90. The role of other cochaperones such p23 (encoded
by  SBA1) is more speculative, since its deletion does not
strongly affect v-Src folding in yeast (Fang et al., 1998), al-
though it is possible that Cdc37 and p23 form a complex
with Hsp90 in animal cells (Hartson et al., 2000).
The ability of Cdc37 to bypass Hsp90 chaperone compo-
nents may occur only under certain conditions such as its
overexpression, which occurs in cancer cells (Stepanova et al.,
2000b). Previous studies have shown that Cdc37 is onco-
Figure 7. Model for v-Src folding by molecular chaperones. 
Nascent v-Src is shown to interact first with Hsp70/Hsp40 as do 
other nascent chains. Hsp90 and Cdc37 recruitment follows 
interaction of Hop/Sti1 with Hsp70. In yeast mutants deleted for 
STI1 or having reduced amounts of Hsp90 (in the hsc82  strain), 
a bypass pathway can promote v-Src folding if sufficient Cdc37 is 
available (dotted line). Our results suggest that the bypass may 
occur in an Hsp90-independent manner, although Hsp90 makes 
the reaction more efficient. See text for further details.1058 The Journal of Cell Biology | Volume 159, Number 6, 2002
genic when overexpressed in mice, and its levels are greatly
increased in human prostate cancer tissues (Stepanova et al.,
2000a,b). These data suggest that Cdc37 levels must be
tightly regulated. We propose that this reflects a form of reg-
ulation whereby Cdc37 is recruited only to those protein ki-
nases that have been through a triage system involving other
chaperones, such as Hsp70/Hsp40 and Hsp90. In this man-
ner, the cell maintains tight control over exposure of client
kinases to Cdc37, and prevents inappropriate stabilization or
activation. Indeed, recent studies demonstrated that Cdk4
induced destabilization by C/EBP  correlates with dissocia-
tion of Cdc37/Hsp90 from Cdk4, suggesting that chaper-
one-dependent stabilization plays an important role in cell
cycle progression (Wang et al., 2002a). It is possible that
Cdc37 overexpression could override such controls and con-
tribute to the transformation process.
Materials and methods
Yeast strains and methods
The W3031b (MAT ) strain background was used for the sti1  and hsc82 
studies. The cdc37  mutants were derived from strain BY4743 as part of S.
cerevisiae gene deletion project (Winzeler et al., 1999). Haploids contain-
ing the cdc37  gene were isolated from tetrads. Yeast cells were grown in
selective media (0.67% yeast nitrogen base, 2% glucose supplemented with
amino acids to complement auxotrophic markers). Yeast transformation
was performed by the lithium acetate method as described previously (Gietz
et al., 1995). Plasmid swap experiments were performed by plating cells
onto media containing 5-fluoroorotic acid to counterselect for plasmids en-
coding URA3 as described previously (Sikorski and Boeke, 1991).
v-Src induction, extract preparation, and Western blot analysis
v-Src was induced from the Gal1–10 promoter by growth in media contain-
ing 2% galactose for 6 h. Cells were grown in 2% raffinose containing me-
dia before induction. Extracts were prepared by glass bead lysis in 20 mM
HEPES, pH 7.5, 100 mM KCl, 0.1 mM EDTA plus protease inhibitors con-
tained in the complete protease inhibitor cocktail by Boehringer. Cells
were lysed with 0.4-mm glass beads using 3  1-min pulses in a bead
beater with 1-min rests in between at 4 C. Extracts were cleared at 14,000 g
for 10 min. Lysates were resolved by denaturing gel electrophoresis and
transferred to Immobilon-P membranes (Millipore). Membranes were
blocked with 5% nonfat dry milk in TTBS (20 mM Tris HCl, pH 7.5, 0.5 M
NaCl, 0.05% Tween-20) overnight. Levels of tyrosine kinase activity were
determined using 4G-10 monoclonal antibodies (Upstate Biotechnology) in
antibody dilution buffer (1  phosphate buffered saline, 3% bovine serum
albumin, 0.05% Tween-20, 0.1% thimersal) for 2 h followed by 3   10
min washes in TTBS and incubation in horseradish peroxidase–conjugated
goat anti–mouse at 1:10,000 dilution for 1 h. The filters were washed 3   5
min in TTBS and treated with a chemiluminescence reagent (Pierce Chemi-
cal Co.) and exposure to x-ray film. V-Src protein was detected using EC10
monoclonal antibodies (a gift from Dr. I. Gelman, Mount Sinai School of
Medicine, New York, NY) using the same conditions.
GST-Hsp90 pull-down assays
Wild-type and sti1  yeast cells expressing GST-Hsp90 (from p2U/HSP82-
GST; a gift from D. Picard, Universite de Geneve, Geneve, Switzerland)
were grown in 200-ml 0.67% yeast nitrogen base plus 2% raffinose to
A600   0.2. Galactose was added to 2% to induce v-Src expression for an
additional6 h. The cells were harvested, and cell extracts were prepared as
described above, but using 20 mM TrisHCl, pH 8, 200 mM NaCl, 1 mM
EDTA, pH 8, 0.5% NP-40, 25  g/ml PMSF plus protease inhibitors con-
tained in the complete protease inhibitor cocktail by Boehringer. The ex-
tracts were adjusted to 3 mg/ml in the same buffer and incubated with 50  l
glutathione-agarose resin (ICN Biomedicals) for 2 h at 4 C. The resin was
collected by low speed centrifugation for 2 min, followed by four washes in
the same buffer. Proteins retained by the resin were dissolved in sample
buffer, resolved by gel electrophoresis, and analyzed by Western blot.
Plasmid construction
The plasmid-encoding poly-histidine (His6) tagged yeast Cdc37 under con-
trol of the yeast ADH1 promoter, pPL2 (TRP1, 2  m), was described previ-
ously (Rao et al., 2001). To construct a URA3 version of this plasmid, the
insert and promoter region were excised with Kpn1 and Sac1, and ligated
into pRS426 (Christianson et al., 1992) to generate pPL3. Truncated forms
of His6Cdc37 were generated by one of two different methods. Cdc37
1–388,
Cdc37
1–274, Cdc37
1–239, Cdc37
1–207, and Cdc37
1–148 were generated by di-
gesting pPL3 with Xb1/Kpn1, Stu1/Kpn1, EcoR1/Kpn1, Pst1/Kpn1, and
Cla1/Kpn1, respectively. The digested plasmids were gel-purified and con-
verted to blunt ends with DNA polymerase I klenow fragment. They were
subsequently ligated with T4 DNA ligase and transformed into E. coli XL1-
Blue. Cdc37
1–335 and Cdc37
1–282 were generated by PCR amplification of
Cdc37 from pRSS2 (Fliss et al., 1997). The upstream primer 5 -AAGCT-
TATGCACCACCACCACCACCACGCCATTGATTACTCTAAG-3  was used
for both constructs. The downstream primer for Cdc37
1–335 was 5 -GGT-
ACCCTACTTGTCCTTGTTGAAGAT-3 , and for Cdc37
1–282 5  -GGTAC-
CCTAACCATGTAACTGATACTC-3 . PCR products were generated with
Pfu1 polymerase in 20 cycles using 50 C annealing temperature. The
products were gel-purified and subcloned first into pCR-Script and then
using HindIII and Kpn1 into pRS426. Plasmids encoding Cdc37
1–388,
Cdc37
1–335, Cdc37
1–239, and Cdc37
1–148 were subsequently subcloned into
pRS423 (His3, 2  m) and pRS313 (His3, CEN/ARS) after PvuII digestion.
The plasmid encoding v-Src used in these studies was constructed by di-
gestion of pRS316-vSrc (a gift from Dr. Frank Boschelli, Wyeth-Ayerst,
Pearl River, NY) with Not1/Xho1, and ligation into pRS425 (Leu2, 2  m).
The plasmid encoding full-length His6 human Cdc37 for expression in E.
coli (pET15b.Cdc37) was described previously (Rao et al., 2001). The trun-
cated His6 human Cdc37
1–173 was prepared by PCR amplification from
pET15b.Cdc37 using the primers 5 -CATATGGTGGACTACAGCGTG-3 
and 5 -GGATCCTCACTTTTGGCTGTCATCCCAGCG-3  using Pfu1 in a
20-cycle reaction at 55 C annealing temperature. The product was gel-
purified and sub-cloned into pCR-Script. The resulting plasmid was di-
gested with Nde1 and BamH1 and the fragment ligated into pET15b.
Cdc37 binding reactions
The expression and purification of His6Cdc37 and His6Cdc37
1–173 and the
binding reactions with v-Src translated in rabbit reticulocyte lysates were
performed exactly as described previously (Rao et al., 2001).
MAP kinase and GR signaling assays
Wild-type and cdc37 /Cdc37
1–148 yeast cells were transformed by pPRE-
LacZ (a gift from K. Morano, University of Texas Medical School, Houston,
TX) that expresses  -galactosidase under control of Ste12 response ele-
ments. These cells were grown to mid-log growth phase at 25 C and incu-
bated with 5  M  -factor (Sigma-Aldrich) for 3 h. Extracts were prepared
as above in 20 mM HEPES, pH 7.5, 100 mM KCl, 0.1 mM EDTA plus pro-
tease inhibitors contained in the complete protease inhibitor cocktail by
Boehringer, and  -galactosidase activity was measured exactly as de-
scribed previously (Caplan et al., 1995). GR activity was assayed by a sim-
ilar assay in the absence or presence of 1  M deoxycorticosterone (Fliss et
al., 1997) using the Tropix kit.
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